On 3 February 2021 the Avicenna Alliance has submitted its feedback to the European Commission’s inception impact assessment on the European Health Data Space.
Through this feedback, Avicenna Members provided the Commission with guidance on how to ensure access to data, the interoperability of data and more importantly which technical developments can enable us to turn the health data into actionable information, including in silico and AI techniques.
The European Health Data Space, covering the exchange and access of primary and secondary use of good quality health data, is eagerly awaited by the in silico medicine community to pursue scientific research and innovations, including the use of computer modelling and simulation (CM&S) in healthcare.
In a nutshell, the members of the Avicenna Alliance from MedTech, Pharmaceutical, digital and life science industries as well as from the academic in silico medicine community and healthcare organisations, represented by the VPH Institute, call on the European Commission to:
The full document can be accessed here